A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.
Connie Franciosi, 80, was part of a trial that looked at using an mRNA vaccine and an immunotherapy drug to prevent the recurrence of melanoma.
Lynn Winkler
hide caption
toggle caption
Lynn Winkler
A personalized vaccine for melanoma cut the risk of cancer returning after five years
New Study Shows How mRNA Vaccines Could Transform Cancer Treatment
Melanoma Vaccine Halves Risk of Recurrence, Metastasis Over 5 Years
Melanoma, a 5 anni vivo il 92% dei pazienti trattato con il vaccino personalizzato - Focus Tumore news - Ansa.it
Breakthrough melanoma vaccine would slash risk of the deadly cancer returning
Melanoma: ecco le novità presentate all’ASCO di Chicago
Melanoma, a 5 anni vivo il 92% trattato con vaccino personalizzato
Cancer vaccine cuts risk of deadly skin cancer returning by half in
Studie: mRNA-Impfung senkt das Risiko für Hautkrebs-Rückfall
mRNA-Impfung gegen Krebs: Steht der Durchbruch bevor?
If the vaccine is effective in a late-stage trial, it would be “paradigm-shifting,” one expert said.
A doctor breaks down a new study on how mRNA vaccines in melanoma research could transform treatment and survival for cancer…
Non è un vaccino preventivo, ma una terapia personalizzata che "addestra" il sistema immunitario a riconoscere il tumore. I dati…
Adjuvant approach will need confirmation from ongoing phase III trial, says expert
Dal congresso mondiale di oncologia ASCO in corso a Chicago arriva una importante conferma sull'efficacia del vaccino a mRna…
Researchers found that mRNA cancer vaccines can recruit an unexpected immune cell to launch powerful tumor-fighting responses,…
